Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst

Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst

Coromega4.8 (360 ratings)
Format:Liquid Quantity: 90 Squeeze Shot(s) · 45 servings
Goals
$48.96 $1.08 per serving

Product analysis

48 out of 100

Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst provides EPA and DHA for ongoing omega-3 nutrition, with possible small joint-comfort benefits for some adults.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality21

The declared oil forms remain unclear despite identifying fish sources and individual omega-3 amounts. That limits a confident comparison of absorption-related quality.

Ingredient Transparency66

EPA and DHA amounts are listed separately, making the active omega-3 content easier to check. Most forms and one source amount remain unclear, so the full oil mixture is less transparent.

Value For Money40

Value for EPA and DHA cannot be determined from a reliable serving-cost comparison. The other listed nutrients do not establish a clear value advantage.

Customer Satisfaction78

Customer feedback is very positive. The smaller review pool makes the feedback more sensitive to individual opinions.

Product Focus60

EPA and DHA provide the clearest purpose through ongoing omega-3 nutrition. The wider eye, skin and focus findings are limited or depend on specific preparations and populations.

Format
Liquid
Container
90 Squeeze Shot(s)
Per serving
$1.08
Customer rating
4.8 · 360 ratings
Report analysis

Goals

Inflammation
Impact
Moderate effect
D+ Ingredient FitF PathwaysA EvidenceA+ Formulation Logic
Vitamin D · 25 mcgFish Oil · 4000 mgVitamin C · 24 mg
Study evidence
Fish Oil Supportive 68 studies
Vitamin C Supportive 50 studies
Vitamin D Supportive 101 studies
Cardiovascular Support
Impact
High effect
B- Ingredient FitC PathwaysB+ EvidenceA+ Formulation Logic
Vitamin D · 25 mcgFish Oil · 4000 mgVitamin C · 24 mg
Study evidence
Fish Oil Supportive 185 studies
Vitamin C Supportive 101 studies
Vitamin D Mixed 170 studies
Impact
High effect
D+ Ingredient FitD PathwaysA+ EvidenceA Formulation Logic
EPA (Eicosapentaenoic Acid) · 1250 mgVitamin D · 25 mcg
Study evidence
Vitamin D Mixed 164 studies
Joint Health
Impact
Moderate effect
C Ingredient FitF PathwaysC+ EvidenceA+ Formulation Logic
Omega-3 · 2400 mg
Study evidence
Omega-3 Supportive 40 studies
Vitamin C Disputed 24 studies
Vitamin D Supportive 111 studies
Skin Health
Impact
High effect
C+ Ingredient FitD PathwaysB EvidenceA+ Formulation Logic
Vitamin C · 24 mgOmega-3 · 2400 mg
Study evidence
Omega-3 Supportive 35 studies
Vitamin C Supportive 53 studies
Eye Health
Impact
High effect
C+ Ingredient FitC PathwaysB+ EvidenceA+ Formulation Logic
Vitamin C · 24 mgEPA (Eicosapentaenoic Acid) · 1250 mg
Study evidence
Vitamin C Disputed 24 studies
Vitamin D Disputed 35 studies

Ingredients

IngredientAmount per servingScore
Calories
40 Calorie(s)
Total Fat
4 Gram(s)
Saturated Fat
0.5 Gram(s)
Cholesterol
25 mg
Vitamin C
24 mg
Vitamin D3
25 mcg
Fish Oil (Anchovy, Mackerel, Sardine)
4000 mg 68
Omega-3 Fatty Acids
2400 mg 82
Eicosapentaenoic Acid
1250 mg 70
Docosahexaenoic Acid
850 mg 68
Stevia Leaf Extract
20 mg
Gluten Free Adults 18–50 Dairy Free Children 4+
Report overview
B Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyB+ Value
Each serving provides 625 mg of EPA at a low cost per gram of EPA. The EPA is in triglyceride form. No oil purification or specific contaminant testing claim is apparent in the available information.
How this ingredient is rated

Active Ingredient Quality & Bioavailability75

The EPA is in triglyceride form. EPA makes up about 31% of the fish oil.
Molecular Form and Bioavailability
The EPA is in triglyceride form.
EPA Concentration Density
EPA makes up about 31% of the fish oil.
Oxidation Protection
Tocopherol is included, though actual protection from oxidation is not established.

Dose, Safety & Label Transparency61

Each serving provides 625 mg of EPA and 425 mg of DHA. No oil purification or specific contaminant testing claim is apparent in the available information.
Absolute EPA Dose per Serving
Each serving provides 625 mg of EPA.
EPA-Centric Ratio
The serving contains 425 mg of DHA, less than the EPA amount.
Purity and Contaminant Testing
No oil purification or specific contaminant testing claim is apparent in the available information.

Value80

The cost per gram of EPA is low.
Price per Gram of EPA
The cost per gram of EPA is low.
Omega-3 · 2400 mg OverallScore82
A+ Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyA+ Value
The serving lists 625 mg EPA and 425 mg DHA. The cost per gram of combined EPA and DHA is low. The omega-3s are in triglycerides form.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

The omega-3s are in triglycerides form. An antioxidant is included, though its identity is not specified here.
Molecular Form & Absorption Potential
The omega-3s are in triglycerides form.
Source Purity & Oxidative Protection
A preferred oil source and antioxidant are noted, though their details are not specified here.

Dose, Safety & Label Transparency55

The serving lists 625 mg EPA and 425 mg DHA. The 1050 mg of EPA and DHA makes up about 53% of the 2000 mg oil.
EPA & DHA Label Specificity
The serving lists 625 mg EPA and 425 mg DHA.
Active Ingredient Concentration
The 1050 mg of EPA and DHA makes up about 53% of the 2000 mg oil.
Third-Party Purity Verification
A qualifying independent certification or purity standard is not noted.

Value100

The cost per gram of combined EPA and DHA is low.
Price per 1000mg of EPA+DHA
The cost per gram of combined EPA and DHA is low.
D+ Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyB+ Value
Each serving provides 1050 mg of EPA and DHA at a moderate cost for the amount supplied. The oil is in triglyceride form. EPA and DHA make up about 53% of the oil.
How this ingredient is rated

Active Ingredient Quality & Bioavailability50

The oil is in triglyceride form. No purification method is recorded. No independent testing claim is recorded.
Omega-3 Molecular Form
The oil is in triglyceride form.
Purification & Filtration Method
No purification method is recorded.
Third-Party Purity & Potency Verification
No independent testing claim is recorded.
Source & Sustainability
A small or wild fish source is indicated, but the species is not specified.

Dose, Safety & Label Transparency79

The serving has 625 mg EPA and 425 mg DHA. EPA and DHA make up about 53% of the oil. An antioxidant is indicated, though its identity is not specified.
Total Active Omega-3 Dose (EPA + DHA)
Each serving provides 1050 mg of EPA and DHA combined.
Omega-3 Potency & Concentration
EPA and DHA make up about 53% of the oil.
EPA & DHA Individual Disclosure
EPA and DHA are listed separately at 625 mg and 425 mg per serving.
Oxidation Protection (Stabilizers)
An antioxidant is indicated, though its identity is not specified.

Value80

The cost is moderate for the EPA and DHA supplied, based on the full serving price.
Cost Per Gram of Active EPA + DHA
The cost is moderate for the EPA and DHA supplied, based on the full serving price.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  2. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  3. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  4. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  5. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  6. Vitamin C may reduce troponin and CKMB levels after PCI and CABG: a meta-analysis.
    Rozemeijer S; Hemilä H; van Baaren M; de Man AME · BMC cardiovascular disorders · 2023
    Meta-analysis872 participants7 studies pooledCardiovascular Support forVitamin C
  7. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A · Circulation · 1998
    Clinical trial49 participantsCardiovascular Support forVitamin C
  8. Vitamin C supplementation improves blood pressure and oxidative stress after acute exercise in patients with poorly controlled type 2 diabetes mellitus: A randomized, placebo-controlled, cross-over study.
    Boonthongkaew C; Tong-Un T; Kanpetta Y; Chaungchot N; Leelayuwat C; Leelayuwat N · The Chinese journal of physiology · 2021
    Randomized trial24 participantsCardiovascular Support forVitamin C
  9. Vascular benefits of vitamin C supplementation against fine particulate air pollution in healthy adults: A double-blind randomised crossover trial.
    Ren J; Liang J; Wang J; Yin B; Zhang F; Li X; Zhu S; Tian H; Cui Q; Song J; Liu G; Ling W; Ma Y · Ecotoxicology and environmental safety · 2022
    Randomized trial58 participantsCardiovascular Support forVitamin C
  10. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes.
    Mullan BA; Young IS; Fee H; McCance DR · Hypertension (Dallas, Tex. : 1979) · 2003
    Randomized trial30 participantsCardiovascular Support forVitamin C
  11. Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
    Norouzzadeh M; Rashedi MH; Mahdavi-Mazdeh G; Kosari A; Shahinfar H · Current atherosclerosis reports · 2026
    Meta-analysisCardiovascular Support Heart Health forVitamin D
  12. A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD.
    Kumar V; Yadav AK; Lal A; Kumar V; Singhal M; Billot L; Gupta KL; Banerjee D; Jha V · Journal of the American Society of Nephrology : JASN · 2017
    Randomized trial120 participantsCardiovascular Support forVitamin D
  13. Randomized, placebo-controlled, double-blind clinical trial on the contributions of vitamin D in the control of cardiovascular risk factors, depressive symptoms and suicide risk.
    Porto C; Petribu K; Barbosa N; Magalhães R; Lira C; Porto AB; Markman-Filho B; Lordsleem A; Calado E; Magalhães J; Sougey E; Silva T; Junio A; Bandeira F; Leão R · American heart journal plus : cardiology research and practice · 2025
    Randomized trial224 participantsCardiovascular Support forVitamin D
  14. Dose responses of vitamin D3 supplementation on arterial stiffness in overweight African Americans with vitamin D deficiency: A placebo controlled randomized trial.
    Raed A; Bhagatwala J; Zhu H; Pollock NK; Parikh SJ; Huang Y; Havens R; Kotak I; Guo DH; Dong Y · PloS one · 2017
    Randomized trial70 participantsCardiovascular Support forVitamin D
  15. Paricalcitol and endothelial function in chronic kidney disease trial.
    Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F · Hypertension (Dallas, Tex. : 1979) · 2015
    Randomized trial88 participantsCardiovascular Support Heart Health forVitamin D
  16. Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
    Meng XT; Shi YY; Hong-Yan Z · Nutricion hospitalaria · 2022
    Meta-analysis5 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  17. Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
    Jiang H; Shi X; Fan Y; Wang D; Li B; Zhou J; Pei C; Ma L · Clinical nutrition (Edinburgh, Scotland) · 2022
    Meta-analysis21 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  18. Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
    Zhong Y; Wang K; Jiang L; Wang J; Zhang X; Xu J; Yao K · European journal of nutrition · 2021
    Meta-analysis167,581 participants11 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  19. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
    Christen WG; Schaumberg DA; Glynn RJ; Buring JE · Archives of ophthalmology (Chicago, Ill. : 1960) · 2011
    Cohort study38,022 participantsEye Health forEPA (Eicosapentaenoic Acid)
  20. Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
    Chen KY; Chan HC; Chan CM · The Journal of nutrition · 2026
    Meta-analysis18 studies pooledEye Health forEPA (Eicosapentaenoic Acid)